Aptus Capital Advisors, LLC

Filing Details

13F-HR • 2025-03-31
SEC
Report Date
2025-03-31
Filing Date
2025-05-13
Total Holdings
1,675
Total Value
9517805189
Accession Number
0001398344-25-009294
Form Type
13F-HR
CIK
0001664193
Manager Name
Aptus Capital Advisors, LLC
Data Enrichment
53% identified
884 identified791 unidentified

Holdings

1,675 positions
Manager:
SEC
Search and click to pin securities to the top
Page 54 of 72
46137V563
46137V563
Shares:
3273(+340.5%)
Value:
$70.3M(+344.9%)
464287531
464287531
Shares:
928(+0.0%)
Value:
$68.5M(-8.4%)
78464A383
78464A383
Shares:
3089(-14.6%)
Value:
$68.1M(-12.7%)
464287788
464287788
Shares:
600(+0.0%)
Value:
$67.7M(+2.0%)
33740F623
33740F623
Shares:
1500(+0.0%)
Value:
$66.5M(-3.4%)
PRECIGEN, INC.
PGEN|74017N105
Shares:
44428(+0.1%)
Value:
$66.2M(+33.1%)
464287374
464287374
Shares:
1450(+0.0%)
Value:
$65.9M(+6.4%)
46641Q837
46641Q837
Shares:
1296(-99.8%)
Value:
$65.6M(-99.8%)
46138E735
46138E735
Shares:
1959(+0.1%)
Value:
$65.6M(+5.9%)
74347G242
74347G242
Shares:
1545(+0.0%)
Value:
$65.0M(-5.0%)
381430602
381430602
Shares:
992(+0.0%)
Value:
$62.9M(-8.2%)
464288752
464288752
Shares:
659(+0.0%)
Value:
$62.7M(-7.9%)
78468R523
78468R523
Shares:
629(+8.3%)
Value:
$62.6M(+8.7%)
46435G193
46435G193
Shares:
2690(+0.0%)
Value:
$62.0M(+1.5%)
82889N103
82889N103
Shares:
1799(+43.9%)
Value:
$62.0M(+32.5%)
464289867
464289867
Shares:
1067(-41.7%)
Value:
$61.4M(-41.4%)
Protalix BioTherapeutics, Inc.
PLX|74365A309
Shares:
23938(+2.5%)
Value:
$61.3M(+39.5%)
78464A359
78464A359
Shares:
798(+2.6%)
Value:
$61.2M(+0.9%)
78463X756
78463X756
Shares:
1072(+0.0%)
Value:
$60.7M(-3.4%)
464288810
464288810
Shares:
1005(-32.8%)
Value:
$60.5M(-30.7%)